Eczacıbaşı to acquire Turkish pharma company Gensenta for $135m
Following the acquisition, Amgen Turkey will maintain its operations and serve its patients in the region.

Following the acquisition, Amgen Turkey will maintain its operations and serve its patients in the region.
Sutro could be eligible for milestone payments of up to $422.5m for each product candidate.
Four programmes of F-star are currently in the clinic while various other undisclosed programmes are in the developmental stage.
AboundBio will receive $14m from Galapagos under the agreed transaction.
Under the deal, an mRNA vaccine that is thermostable at refrigerator temperatures will be produced.
Pfizer intends to commence the Phase III clinical trial of the vaccine in the third quarter of this year.
The boards of directors of Zura Bio and JATT granted approval for the business combination.
Invectys’ researchers and the CTMC team will jointly develop an HLA-G targeted CAR T cell therapy for solid tumours.
Thank you for subscribing to Pharmaceutical Technology